The global specialty active pharmaceutical ingredients market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for specialty active pharmaceutical ingredients in various therapeutic areas such as CNS, cardiology, genitourinary/hormonal drugs, rheumatology and diabetes. The growing number of patients suffering from chronic diseases such as diabetes and cancer are driving the demand for these products.
The global specialty active pharmaceutical ingredients market by type includes steroidal API, peptide API, carbohydrate API and small molecule API. Steroidal APIs are used in various therapeutic areas such as CNS (central nervous system), cardiology (heart), genitourinary/hormonal drugs (sexual organs) and rheumatology (joints). Peptide APIs are used in CNS therapeutics for treating neurological disorders like Alzheimer’s disease or Parkinson’s disease; cardiovascular therapeutics for treating heart failure or hypertension; genitourinary/hormonal drugs for treating prostate cancer or breast cancer; and rheumatology therapeutics for treating arthritis or osteoporosis. Carbohydrate APIs are used in cardiovascular therapeutics to treat high blood pressure or heart failure; diabetes therapeutics to treat type 2 diabetes mellitus; oncology therapetics to treat leukemia or lymphoma; and rheumatology therapies to treat arthritis or osteoporosis. Small molecule APIs are used in cardiovascular therapies like hypertension treatment with beta blockers like propranolol hydrochloride which is a beta-adrenergic receptor antagonist that blocks the action of adrenaline on receptors found on cells throughout the body including those found in blood vessels which causes them to relax thereby lowering blood pressure levels.; diabetic therapies like insulin therapy which is a hormone that regulates glucose levels by stimulating cells called insulin-producing cells located within the pancreas called beta cells.; oncological therapies like chemotherapy which uses anti-cancer medicines that kill fast dividing cells including cancerous ones.; And finally rheumatic therapy treatments such as methotrexate sodium injection which is an antimetabolite drug that inhibits DNA synthesis by blocking dihydrofolate reductase enzyme activity thereby inhibiting cell division., respectively.
- The global population is increasing and aging, which will lead to an increase in the number of people with chronic diseases.
- The global population is becoming more urbanized, which will lead to an increase in the number of people living in cities and a decrease in rural populations.
- There are new technologies that can be used to develop drugs for rare diseases, such as gene therapy and personalized medicine.
- The pharmaceutical industry is consolidating due to mergers and acquisitions.
Industry Growth Insights published a new data on “Specialty Active Pharmaceutical Ingredients Market”. The research report is titled “Specialty Active Pharmaceutical Ingredients Market research by Types (Steroidal API, Peptide API, Carbohydrate API, Small Molecule API, High Potency AP), By Applications (CNS, Cardiovascular, Genitourinary/Hormonal Drugs, Rheumatology, Diabetes, Oncology, Others), By Players/Companies Sanofi, Cambrex, Almac, Johnson Matthey, PolyPeptide, AmbioPharm, Avecia, ST Pharm, Biospring”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Specialty Active Pharmaceutical Ingredients Market Research Report
By Type
Steroidal API, Peptide API, Carbohydrate API, Small Molecule API, High Potency AP
By Application
CNS, Cardiovascular, Genitourinary/Hormonal Drugs, Rheumatology, Diabetes, Oncology, Others
By Companies
Sanofi, Cambrex, Almac, Johnson Matthey, PolyPeptide, AmbioPharm, Avecia, ST Pharm, Biospring
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Specialty Active Pharmaceutical Ingredients Market Report Segments:
The global Specialty Active Pharmaceutical Ingredients market is segmented on the basis of:
Types
Steroidal API, Peptide API, Carbohydrate API, Small Molecule API, High Potency AP
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
CNS, Cardiovascular, Genitourinary/Hormonal Drugs, Rheumatology, Diabetes, Oncology, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Cambrex
- Almac
- Johnson Matthey
- PolyPeptide
- AmbioPharm
- Avecia
- ST Pharm
- Biospring
Highlights of The Specialty Active Pharmaceutical Ingredients Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Steroidal API
- Peptide API
- Carbohydrate API
- Small Molecule API
- High Potency AP
- By Application:
- CNS
- Cardiovascular
- Genitourinary/Hormonal Drugs
- Rheumatology
- Diabetes
- Oncology
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Specialty Active Pharmaceutical Ingredients Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Specialty Active Pharmaceutical Ingredients (SAPIs) are a type of drug that is specifically designed to treat a certain medical condition. SAPIs are often more expensive than traditional drugs, but they may be more effective in treating specific conditions.
Some of the major companies in the specialty active pharmaceutical ingredients market are Sanofi, Cambrex, Almac, Johnson Matthey, PolyPeptide, AmbioPharm, Avecia, ST Pharm, Biospring.
The specialty active pharmaceutical ingredients market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Specialty Active Pharmaceutical Ingredients Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Specialty Active Pharmaceutical Ingredients Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Specialty Active Pharmaceutical Ingredients Market - Supply Chain
4.5. Global Specialty Active Pharmaceutical Ingredients Market Forecast
4.5.1. Specialty Active Pharmaceutical Ingredients Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Specialty Active Pharmaceutical Ingredients Market Size (000 Units) and Y-o-Y Growth
4.5.3. Specialty Active Pharmaceutical Ingredients Market Absolute $ Opportunity
5. Global Specialty Active Pharmaceutical Ingredients Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Specialty Active Pharmaceutical Ingredients Market Size and Volume Forecast by Type
5.3.1. Steroidal API
5.3.2. Peptide API
5.3.3. Carbohydrate API
5.3.4. Small Molecule API
5.3.5. High Potency AP
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Specialty Active Pharmaceutical Ingredients Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Specialty Active Pharmaceutical Ingredients Market Size and Volume Forecast by Application
6.3.1. CNS
6.3.2. Cardiovascular
6.3.3. Genitourinary/Hormonal Drugs
6.3.4. Rheumatology
6.3.5. Diabetes
6.3.6. Oncology
6.3.7. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Specialty Active Pharmaceutical Ingredients Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Specialty Active Pharmaceutical Ingredients Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Specialty Active Pharmaceutical Ingredients Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Specialty Active Pharmaceutical Ingredients Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Specialty Active Pharmaceutical Ingredients Demand Share Forecast, 2019-2026
9. North America Specialty Active Pharmaceutical Ingredients Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Specialty Active Pharmaceutical Ingredients Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Specialty Active Pharmaceutical Ingredients Market Size and Volume Forecast by Application
9.4.1. CNS
9.4.2. Cardiovascular
9.4.3. Genitourinary/Hormonal Drugs
9.4.4. Rheumatology
9.4.5. Diabetes
9.4.6. Oncology
9.4.7. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Specialty Active Pharmaceutical Ingredients Market Size and Volume Forecast by Type
9.7.1. Steroidal API
9.7.2. Peptide API
9.7.3. Carbohydrate API
9.7.4. Small Molecule API
9.7.5. High Potency AP
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Specialty Active Pharmaceutical Ingredients Demand Share Forecast, 2019-2026
10. Latin America Specialty Active Pharmaceutical Ingredients Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Specialty Active Pharmaceutical Ingredients Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Specialty Active Pharmaceutical Ingredients Market Size and Volume Forecast by Application
10.4.1. CNS
10.4.2. Cardiovascular
10.4.3. Genitourinary/Hormonal Drugs
10.4.4. Rheumatology
10.4.5. Diabetes
10.4.6. Oncology
10.4.7. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Specialty Active Pharmaceutical Ingredients Market Size and Volume Forecast by Type
10.7.1. Steroidal API
10.7.2. Peptide API
10.7.3. Carbohydrate API
10.7.4. Small Molecule API
10.7.5. High Potency AP
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Specialty Active Pharmaceutical Ingredients Demand Share Forecast, 2019-2026
11. Europe Specialty Active Pharmaceutical Ingredients Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Specialty Active Pharmaceutical Ingredients Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Specialty Active Pharmaceutical Ingredients Market Size and Volume Forecast by Application
11.4.1. CNS
11.4.2. Cardiovascular
11.4.3. Genitourinary/Hormonal Drugs
11.4.4. Rheumatology
11.4.5. Diabetes
11.4.6. Oncology
11.4.7. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-oY Growth Projections by Application
11.7. Europe Specialty Active Pharmaceutical Ingredients Market Size and Volume Forecast by Type
11.7.1. Steroidal API
11.7.2. Peptide API
11.7.3. Carbohydrate API
11.7.4. Small Molecule API
11.7.5. High Potency AP
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Specialty Active Pharmaceutical Ingredients Demand Share, 2019-2026
12. Asia Pacific Specialty Active Pharmaceutical Ingredients Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Specialty Active Pharmaceutical Ingredients Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Specialty Active Pharmaceutical Ingredients Market Size and Volume Forecast by Application
12.4.1. CNS
12.4.2. Cardiovascular
12.4.3. Genitourinary/Hormonal Drugs
12.4.4. Rheumatology
12.4.5. Diabetes
12.4.6. Oncology
12.4.7. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Specialty Active Pharmaceutical Ingredients Market Size and Volume Forecast by Type
12.7.1. Steroidal API
12.7.2. Peptide API
12.7.3. Carbohydrate API
12.7.4. Small Molecule API
12.7.5. High Potency AP
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Specialty Active Pharmaceutical Ingredients Demand Share, 2019-2026
13. Middle East & Africa Specialty Active Pharmaceutical Ingredients Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Specialty Active Pharmaceutical Ingredients Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Specialty Active Pharmaceutical Ingredients Market Size and Volume Forecast by Application
13.4.1. CNS
13.4.2. Cardiovascular
13.4.3. Genitourinary/Hormonal Drugs
13.4.4. Rheumatology
13.4.5. Diabetes
13.4.6. Oncology
13.4.7. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Specialty Active Pharmaceutical Ingredients Market Size and Volume Forecast by Type
13.7.1. Steroidal API
13.7.2. Peptide API
13.7.3. Carbohydrate API
13.7.4. Small Molecule API
13.7.5. High Potency AP
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Specialty Active Pharmaceutical Ingredients Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Specialty Active Pharmaceutical Ingredients Market: Market Share Analysis
14.2. Specialty Active Pharmaceutical Ingredients Distributors and Customers
14.3. Specialty Active Pharmaceutical Ingredients Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sanofi
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cambrex
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Almac
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Johnson Matthey
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. PolyPeptide
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. AmbioPharm
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Avecia
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. ST Pharm
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Biospring
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
